Helicobacter pylori immunology and vaccines

Helicobacter

Volumn 13, Issue SUPPL.1, 2008, Pages 18-22

  Vorobjova, Tamara ^a   Watanabe, Tomohiro ^b   Chiba, Tsutomu ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; IFN ; IL 12; IL 17; Nod like receptor; Peyer's patches; Regulatory T cells; Toll like receptor; Vaccine

Indexed keywords

HELICOBACTER PYLORI VACCINE; UNCLASSIFIED DRUG; UREB 138;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ARTICLE; CARCINOGENESIS; CHRONIC GASTRITIS; ESCHERICHIA COLI; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL;

BACTERIAL PROTEINS; BACTERIAL VACCINES; CYTOKINES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, NATURAL; PEYER'S PATCHES; STOMACH NEOPLASMS; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 49249107350     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2008.00636.x     Document Type: Article

References (30)

1. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007 133 : 288 308.
2. Amedei A, Cappon A, Codolo G, et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006 116 : 1092 101.
3. Ferrero RL. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 2005 42 : 879 85.
4. Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004 5 : 1166 74.
5. Rad R, Brenner L, Krug A, et al. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 2007 133 : 150 63 e3.
6. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003 301 : 1099 102.
7. Torres VJ, VanCompernolle SE, Sundrud MS, Unutmaz D, Cover TL. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol 2007 179 : 5433 40.
8. Sewald X, Gebert-Vogl B, Prassl S, et al. Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe 2008 3 : 20 9.
9. Hisatsune J, Nakayama M, Isomoto H, et al. Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-{kappa}B activation. J Immunol 2008 180 : 5017 27.
10. Kiriya K, Watanabe N, Nishio A, et al. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis. Int Immunol 2007 19 : 435 46.
11. Nagai S, Mimuro H, Yamada T, Baba Y, Moro K, Nochi T, Kiyono H, Suzuki T, Sasakawa C, Koyasu S. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc Natl Acad Sci U S A 2007 104 : 8971 6.
12. Rad R, Brenner L, Bauer S, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006 131 : 525 37.
13. Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, Reyes VE. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 2006 176 : 3000 9.
14. Beswick EJ, Pinchuk IV, Das S, Powell DW, Reyers VE. Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+CD25+ Foxp3+ regulatory T cells. Infect Immun 2007 75 : 4334 41.
15. Harris PR, Wright SW, Serrano C, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008 134 : 491 9.
16. Fukui T, Nishio A, Okazaki K, et al. Cross-primed CD8+ cytotoxic T cells induce severe Helicobacter-associated gastritis in the absence of CD4+ T cells. Helicobacter 2007 12 : 486 97.
17. Pellicano A, Sebkova L, Monteleone G, Guarnieri G, Imeneo M, Pallone F, Luzza F. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa. Infect Immun 2007 75 : 1738 44.
18. Yamauchi K, Choi IJ, Lu H, Ogiwara H, Graham DY, Yamaoka Y. Regulation of IL-18 in Helicobacter pylori infection. J Immunol 2008 180 : 1207 16.
19. Watanabe T, Katsukura H, Shirai Y, Yamori M, Nishi T, Chiba T, Kita T, Wakatsuki Y. A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology 2003 38 : 403 12.
20. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008 28 : 454 67.
21. O'Keeffe J, Moran AP. Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter 2008 13 : 1 19.
22. Caruso R, Fina D, Paoluzi OA, et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008 38 : 470 8.
23. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki I-M, Honjo T, Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007 13 : 470 6.
24. Endo Y, Marusawa H, Kinoshita K, Morisawa T, Sakurai T, Okazaki IM, Watashi K, Shimotono K, Honjo T, Chiba T. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kB signaling. Oncogene 2007 26 : 5587 95.
25. D'Elios MM, Andersen LP. Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter 2007 12 : 15 9.
26. Morihara F, Hifumi E, Yamada M, Nishizono A, Uda T. Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori. Biotechnol Bioeng 2008 100 : 634 43.
27. Zhao W, Wu W, Xu X. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Vaccine 2007 25 : 7664 73.
28. Xu C, Li ZS, Du YQ, Gong YF, Yang H, Sun B, Jin J. Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H. pylori ureB and IL-2. World J Gastroenterol 2007 13 : 939 44.
29. Taylor JM, Ziman ME, Fong J, Solnick JV, Vajdy M. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun 2007 75 : 3462 9.
30. Sutton P, Doidge C, Pinczower G, Wilson J, Harbour S, Swierczak A, Lee A. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background. FEMS Immunol Med Microbiol 2007 50 : 213 9.